These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 46418)

  • 1. Letter: Prednisone in Duchenne muscular dystrophy.
    Munsat TL; Walton JN
    Lancet; 1975 Feb; 1(7901):276-7. PubMed ID: 46418
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Prednisone in Duchenne muscular dystrophy.
    Lancet; 1975 Feb; 1(7903):397-8. PubMed ID: 46545
    [No Abstract]   [Full Text] [Related]  

  • 3. Prednisone in Duchenne muscular dystrophy.
    Drachman DB; Toyka KV; Myer E
    Lancet; 1974 Dec; 2(7894):1409-12. PubMed ID: 4140328
    [No Abstract]   [Full Text] [Related]  

  • 4. Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit.
    DeSilva S; Drachman DB; Mellits D; Kuncl RW
    Arch Neurol; 1987 Aug; 44(8):818-22. PubMed ID: 3632394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone.
    Brooke MH; Fenichel GM; Griggs RC; Mendell JR; Moxley RT; Miller JP; Kaiser KK; Florence JM; Pandya S; Signore L
    Arch Neurol; 1987 Aug; 44(8):812-7. PubMed ID: 3632393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisone in Duchenne dystrophy.
    Dubowitz V
    Neuromuscul Disord; 1991; 1(3):161-3. PubMed ID: 1822789
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.
    Fenichel GM; Florence JM; Pestronk A; Mendell JR; Moxley RT; Griggs RC; Brooke MH; Miller JP; Robison J; King W
    Neurology; 1991 Dec; 41(12):1874-7. PubMed ID: 1745340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steroid treatment of Duchenne's muscular dystrophy].
    Luz Aviles C; Gutiérrez C; Novoa F; Gil E; Stuardo A
    Rev Chil Pediatr; 1982; 53(3):187-91. PubMed ID: 6760264
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring the effects of prednisone in Duchenne dystrophy.
    Stern LM; Tomas FM; Burgoyne J
    J Paediatr Child Health; 1996 Apr; 32(2):196. PubMed ID: 9156536
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-term effects of corticosteroid therapy on cardiac and skeletal muscles in muscular dystrophies.
    Hussein G; Mansour L; Ghafar HA; Mostafa FA; Fawaz L
    J Investig Med; 2014 Aug; 62(6):875-9. PubMed ID: 24866459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.
    Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Pestronk A; Miller JP
    Arch Neurol; 1991 Apr; 48(4):383-8. PubMed ID: 2012511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.
    Hussein MR; Hamed SA; Mostafa MG; Abu-Dief EE; Kamel NF; Kandil MR
    Int J Exp Pathol; 2006 Dec; 87(6):451-61. PubMed ID: 17222213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group.
    Kissel JT; Burrow KL; Rammohan KW; Mendell JR
    Neurology; 1991 May; 41(5):667-72. PubMed ID: 2027481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids in Duchenne muscular dystrophy: a reappraisal.
    Wong BL; Christopher C
    J Child Neurol; 2002 Mar; 17(3):183-90. PubMed ID: 12026233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy.
    Kissel JT; Lynn DJ; Rammohan KW; Klein JP; Griggs RC; Moxley RT; Cwik VA; Brooke MH; Mendell JR
    Neurology; 1993 Mar; 43(3 Pt 1):532-6. PubMed ID: 8450996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [For the present Duchenne' disease should not be treated with prednisone].
    Jennekens FG; de Visser M; Wintzen AR; Wokke JH
    Ned Tijdschr Geneeskd; 1996 May; 140(21):1109-11. PubMed ID: 8692335
    [No Abstract]   [Full Text] [Related]  

  • 17. Ineffectiveness of allopurinol in Duchenne muscular dystrophy.
    Doriguzzi C; Bertolotto A; Ganzit GP; Mongini T; Palmucci L
    Muscle Nerve; 1981; 4(2):176-8. PubMed ID: 7010155
    [No Abstract]   [Full Text] [Related]  

  • 18. [A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. A one-year follow-up study of 14 children].
    Desnuelle C; Serratrice G; N'guyen VK; Richelme C; Pinsard N
    Arch Fr Pediatr; 1989 Dec; 46(10):759-65. PubMed ID: 2697199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.
    Mendell JR; Moxley RT; Griggs RC; Brooke MH; Fenichel GM; Miller JP; King W; Signore L; Pandya S; Florence J
    N Engl J Med; 1989 Jun; 320(24):1592-7. PubMed ID: 2657428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months).
    Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Pestronk A; Miller JP; Cwik VA; Pandya S; Robison J
    Neurology; 1993 Mar; 43(3 Pt 1):520-7. PubMed ID: 8450994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.